Showing results (101-110 of 179) with videos related to
Sort By:
Pageof 18
Translational Psychiatry|June 15, 2016
Elevated paternal glucocorticoid exposure alters the small noncoding RNA profile in sperm and modifies anxiety and depressive phenotypes in the offspringA K Short, K A Fennell, V M Perreau, et al.Histopathology|November 6, 2020
Inclusion of multiple high-risk histopathological criteria improves the prediction of adjuvant chemotherapy efficacy in lung adenocarcinomaMarco Sereno, Zhangyi He, Claire R Smith, et al.Lung Cancer (Amsterdam, Netherlands)|January 11, 2005
Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesotheliomaDean A Fennell, Jeremy P C Steele, Jonathan Shamash, et al.Cell Death & Disease|July 23, 2013
SAHA overcomes FLIP-mediated inhibition of SMAC mimetic-induced apoptosis in mesotheliomaN Crawford, I Stasik, C Holohan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2020
Ganetespib in Combination with Pemetrexed-Platinum Chemotherapy in Patients with Pleural Mesothelioma (MESO-02): A Phase Ib TrialDean A Fennell, Sarah Danson, Penella J Woll, et al.Plos One|September 25, 2014
Association between gene expression profiles and clinical outcome of pemetrexed-based treatment in patients with advanced non-squamous non-small cell lung cancer: exploratory results from a phase II studyDean A Fennell, Scott P Myrand, Tuan S Nguyen, et al.European Journal of Cancer (Oxford, England : 1990)|August 27, 2014
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validationBaktiar Hasan, Laurent Greillier, Athanasios Pallis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2019
Randomized Phase III Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, With Docetaxel Versus Docetaxel in Advanced Non-Small-Cell Lung Cancer (GALAXY-2)Rathi N Pillai, Dean A Fennell, Vladimir Kovcin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletionPeter W Szlosarek, Astero Klabatsa, Arben Pallaska, et al.Cell Death & Disease|December 21, 2012
Acquired differential regulation of caspase-8 in cisplatin-resistant non-small-cell lung cancerI Paul, A D Chacko, I Stasik, et al.Pageof 18